Immunovant Inc (IMVT)

Cost of Revenue

$206.00K

TTM · Period ending: · USD

IMVT logo

IMVT Cost of Revenue

Latest reported$206.00K
IMVT TTM Cost of Revenue ($462.90K → $206.00K)
High-resolution chart · PNG

IMVT cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Immunovant Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
206,000
206,000
206,000
105,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
395,157
462,899
462,899
462,899
67,742
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.